Login to Your Account

Acambis Appears To Have Lost Vaccine Deal To Bavarian Nordic

By Cormac Sheridan

Wednesday, November 15, 2006
Shares in Acambis plc plunged 38 percent on the London Stock Exchange Tuesday on news that the U.S. Department of Health and Human Services is no longer considering its bid for a government contract to supply a stockpile of next-generation smallpox vaccines, based on the modified vaccinia ankara (MVA) vector. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription